Chicago: Move Over, Agonists; Make Way for Modulators
details, see Neuroscience 2009 abstracts.—Esther Landhuis. This is Part 2 of a three-part series. See also
373 RESULTS
You searched Landhuis
Sort By:
details, see Neuroscience 2009 abstracts.—Esther Landhuis. This is Part 2 of a three-part series. See also
approaches, see Part 2. For more detail, see Neuroscience 2009 abstracts.—Esther Landhuis. This is Part 1 of
identify patients who can be treated before their brains are too damaged to be repaired.”—Esther Landhuis
option.—Esther Landhuis. This is Part 1 of a two-part series. See Part 2 Q&A With Sue Anderson, FDA
(see ARF related conference story).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2246
at the behavior of single neurons,” he told ARF.—Esther Landhuis None
risk or to guide personalized genomic strategies relevant to drug response.—Esther Landhuis None
Landhuis None http://www.alzforum.org/new/detail.asp?id=2231 Alzheimer's Disease Acetylcholine Aβ
findings at ICAD in Vienna.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2228
see Conn et al., 2009 and Fisher, 2008).—Esther Landhuis None
Baltimore, Maryland, have used the technology to detect early-stage colorectal cancer.—Esther Landhuis None
Landhuis None http://www.alzforum.org/new/detail.asp?id=2221 Clinical Research Genetics Imaging
get into the nervous system or not?”—Esther Landhuis None
correlates with increased risk of AD and vascular dementia 30 years later.—Esther Landhuis None
dysregulated gene-jumping frequencies compared to healthy people.—Esther Landhuis None